AstraZeneca PLC (LSE:AZN) — Stock Price

GBX11990.00 GBX
▲ 0.79% today

AstraZeneca PLC (LSE:AZN) is currently trading at GBX11990.00 GBX, up 0.79% today. Over the past 52 weeks, shares have ranged between GBX10956.00 and GBX15542.00. This page tracks AstraZeneca PLC's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see AstraZeneca PLC stock valuation.

AstraZeneca PLC (AZN) Stock Price Chart — Daily History & Trading Volume

The chart below tracks AstraZeneca PLC's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

AstraZeneca PLC Income Statement — Revenue, Profit & Earnings by Year

AstraZeneca PLC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue GBX58.74 Billion GBX52.94 Billion GBX46.58 Billion GBX44.25 Billion GBX37.11 Billion
Cost of Revenue GBX10.63 Billion GBX13.25 Billion GBX12.14 Billion GBX16.21 Billion GBX14.51 Billion
Gross Profit GBX48.11 Billion GBX39.70 Billion GBX34.45 Billion GBX28.04 Billion GBX22.60 Billion
Research & Development GBX14.23 Billion GBX11.96 Billion GBX10.52 Billion GBX9.62 Billion GBX8.38 Billion
SG&A GBX19.93 Billion GBX19.67 Billion GBX17.68 Billion GBX18.95 Billion GBX95.00 Million
Total Operating Expenses GBX34.36 Billion GBX27.18 Billion GBX24.88 Billion GBX22.99 Billion GBX19.79 Billion
Operating Income GBX13.74 Billion GBX12.52 Billion GBX9.57 Billion GBX5.05 Billion GBX2.81 Billion
EBITDA GBX19.83 Billion GBX14.86 Billion GBX13.20 Billion GBX8.63 Billion GBX4.59 Billion
EBIT GBX14.10 Billion GBX9.90 Billion GBX8.18 Billion GBX3.39 Billion GBX562.01 Million
Interest Expense GBX1.69 Billion GBX1.36 Billion GBX1.15 Billion GBX887.04 Million GBX759.15 Million
Income Before Tax GBX12.40 Billion GBX8.51 Billion GBX7.02 Billion GBX2.50 Billion GBX-259.92 Million
Income Tax Expense GBX2.17 Billion GBX1.62 Billion GBX953.81 Million GBX-790.26 Million GBX-372.71 Million
Net Income GBX10.22 Billion GBX6.89 Billion GBX6.06 Billion GBX3.28 Billion GBX109.85 Million

AstraZeneca PLC Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes AstraZeneca PLC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets GBX114.07 Billion GBX104.03 Billion GBX101.12 Billion GBX96.48 Billion GBX105.36 Billion
Total Current Assets GBX28.72 Billion GBX25.80 Billion GBX24.84 Billion GBX22.59 Billion GBX26.14 Billion
Cash & Equivalents — — — — —
Short-term Investments GBX30.00 Million GBX165.83 Million GBX120.97 Million GBX77.00 Million GBX68.72 Million
Net Receivables GBX16.34 Billion GBX13.08 Billion GBX11.83 Billion GBX9.19 Billion GBX8.76 Billion
Inventory GBX6.56 Billion GBX5.28 Billion GBX5.38 Billion GBX4.70 Billion GBX8.95 Billion
Property, Plant & Equipment — — — GBX9.45 Billion GBX10.17 Billion
Goodwill GBX21.24 Billion GBX21.02 Billion GBX19.88 Billion GBX19.82 Billion GBX20.00 Billion
Total Liabilities GBX65.36 Billion GBX63.16 Billion GBX61.95 Billion GBX59.42 Billion GBX66.08 Billion
Total Current Liabilities GBX30.62 Billion GBX27.87 Billion GBX30.54 Billion GBX26.29 Billion GBX22.59 Billion
Long-term Debt GBX24.71 Billion GBX26.51 Billion GBX22.36 Billion GBX22.96 Billion GBX28.13 Billion
Net Debt GBX23.91 Billion GBX24.63 Billion GBX22.57 Billion GBX22.98 Billion GBX24.36 Billion
Total Stockholder Equity GBX48.67 Billion GBX40.79 Billion GBX39.14 Billion GBX37.04 Billion GBX39.27 Billion
Retained Earnings GBX10.97 Billion GBX3.16 Billion GBX1.50 Billion GBX-574.00 Million GBX1.71 Billion

AstraZeneca PLC Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how AstraZeneca PLC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow GBX14.57 Billion GBX11.86 Billion GBX10.35 Billion GBX9.81 Billion GBX5.96 Billion
Capital Expenditures GBX5.91 Billion GBX4.59 Billion GBX3.78 Billion GBX2.57 Billion GBX2.20 Billion
Free Cash Flow GBX8.67 Billion GBX7.28 Billion GBX6.57 Billion GBX7.24 Billion GBX3.76 Billion
Investing Cash Flow GBX-6.81 Billion GBX-7.98 Billion GBX-4.06 Billion GBX-2.96 Billion GBX-11.06 Billion
Financing Cash Flow GBX-7.54 Billion GBX-4.00 Billion GBX-6.57 Billion GBX-6.82 Billion GBX3.65 Billion
Dividends Paid GBX4.97 Billion GBX4.63 Billion GBX4.48 Billion GBX4.36 Billion GBX3.86 Billion
Stock-Based Compensation — — GBX579.00 Million GBX619.00 Million GBX615.00 Million
Depreciation GBX5.73 Billion GBX5.07 Billion GBX4.93 Billion GBX5.48 Billion GBX6.53 Billion
Change in Cash GBX269.00 Million GBX-208.00 Million GBX-346.00 Million GBX-55.00 Million GBX-1.51 Billion

AstraZeneca PLC Earnings History — EPS Actual vs. Analyst Estimates

Track AstraZeneca PLC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 29, 2026 2.58 2.52 +2.35%
Feb 05, 2026 2.12 2.13 -0.47%
Nov 06, 2025 2.38 2.24 +6.25%
Jul 29, 2025 2.17 2.15 +0.93%
Apr 29, 2025 2.49 2.24 +11.16%
Feb 06, 2025 2.09 2.08 +0.48%
Nov 12, 2024 2.08 2.04 +1.96%
Jul 25, 2024 1.98 1.96 +1.02%